Metraipolis › archive › dc_f485aad4bc39
Prognostic Value of Neutrophil Percentage-Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors — Europe PMC PMID:42346202
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42346202
- DOI
- 10.3390/curroncol33060302
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:40:29.872Z
- SHA-256 of the archived text
ac43fe9d10b06597ca6f5646574ea72d14b1305105fe4d5c637cd35ca3d01f08- Stable URL of this page
https://metraipolis.com/documento/dc_f485aad4bc39
How to cite
Prognostic Value of Neutrophil Percentage-Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors — Europe PMC PMID:42346202 — Europe PMC (en), https://europepmc.org/article/MED/42346202 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f485aad4bc39 (Metraipolis archive dc_f485aad4bc39, sha256 ac43fe9d10b06597ca6f5646574ea72d14b1305105fe4d5c637cd35ca3d01f08)
BibTeX
@misc{dcf485aad4bc39,
title = {Prognostic Value of Neutrophil Percentage-Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors — Europe PMC PMID:42346202},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42346202},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f485aad4bc39; sha256 ac43fe9d10b06597ca6f5646574ea72d14b1305105fe4d5c637cd35ca3d01f08},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42346202. Agents can read the archived copy with the MCP tool read_document.